United States · Venture startup

Who invested in MedGene Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2023, from 1 source

Latest round
VentureAug 2023
Investors
1
See who backed them

The rounds

  1. Aug 2023
    VentureAmount undisclosed

    Source recorded

Founders and team

From the SEC filings it signed: 1 on the team.

  • Yonghan ParkExecutive Officer, Directori

On the board, as filediJames SongTae-erk Kim

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about MedGene Therapeutics

Who invested in MedGene Therapeutics?

MedGene Therapeutics's investors include Korea Tech Incubator Program For Startup.

How much has MedGene Therapeutics raised?

MedGene Therapeutics has raised 1 round since 2023, none with a disclosed amount.

When did MedGene Therapeutics last raise?

MedGene Therapeutics's most recent round was a Venture in Aug 2023.

Who backed MedGene Therapeutics first?

MedGene Therapeutics's first round on record, in Aug 2023, was backed by Korea Tech Incubator Program For Startup.

What stage is MedGene Therapeutics at?

MedGene Therapeutics's latest named round is a Venture, in Aug 2023.

Where is MedGene Therapeutics based?

MedGene Therapeutics is based in the United States.

Companies like MedGene Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.